Free Trial
NASDAQ:LEXXW

Lexaria Bioscience (LEXXW) Stock Price, News & Analysis

$1.23
-0.01 (-0.81%)
(As of 06/20/2024 ET)
Today's Range
$1.23
$1.31
50-Day Range
$0.51
$1.63
52-Week Range
$0.05
$2.50
Volume
6,771 shs
Average Volume
17,955 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

LEXXW Stock Price History

LEXXW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive LEXXW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:LEXXW
Web
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$404,726.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Christopher A. Bunka (Age 62)
    Chairman & CEO
    Comp: $291.19k
  • Mr. John M. Docherty M.Sc. (Age 55)
    President & Director
    Comp: $290.46k
  • Mr. Nelson D. Cabatuan CPA (Age 45)
    Chief Financial Officer
  • Kristin Hamilton
    Director of Operations
  • Vanessa Carle
    Head of Legal
  • Dr. Philip N. Ainslie Ph.D.
    Advisor & Consultant

LEXXW Stock Analysis - Frequently Asked Questions

How have LEXXW shares performed in 2024?

Lexaria Bioscience's stock was trading at $0.45 at the beginning of the year. Since then, LEXXW stock has increased by 172.8% and is now trading at $1.2277.
View the best growth stocks for 2024 here
.

Are investors shorting Lexaria Bioscience?

Lexaria Bioscience saw a increase in short interest in May. As of May 31st, there was short interest totaling 5,400 shares, an increase of 92.9% from the May 15th total of 2,800 shares. Based on an average daily trading volume, of 17,600 shares, the short-interest ratio is presently 0.3 days.
View Lexaria Bioscience's Short Interest
.

How do I buy shares of Lexaria Bioscience?

Shares of LEXXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LEXXW) was last updated on 6/21/2024 by MarketBeat.com Staff

From Our Partners